New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients

British Journal of Haematology, 03/26/2012

The authors report here a new multigene prognostic index for chronic myelomonocytic leukaemia (CMML), independent of the gene expression measurement method, which could be used as a powerful tool to predict clinical outcome and help physicians to evaluate criteria for treatments.

Print Article Summary Cat 2 CME Report